RUNX1 and leukemia: We analysed which TFs are predicted to be enriched in MLL-AF9 blasts and revealed a set of TFs that are well documented to have a role in MLL-AF9 leukemias, such as MECOM (EVI1), but also HOXA9, and HOXA76,49.